Normally, the fact that Commonwealth Bank of Australia (ASX: CBA) is selling down its stake in a company wouldn't be a trigger to buy, but stay with me on this one.
The company under the microscope in this case is Count Ltd (ASX: CUP), which recently had some good news.

Image source: Getty Images
Court case comes to an end
Count was being sued in a class action lodged in 2020, with the court case related to the receipt of product commissions from 2014 to 2020.
Count won the case on its first hearing, and told the ASX in a statement on 19 November that it had also won the appeal to the Full Court of the Federal Court.
This is undeniably good news for the company, which can now get on with business without the case taking up management time and potentially scaring off investors.
So how does this involve Commonwealth Bank?
The bank sold its Count Financial business to Count, then called CountPlus, in June 2019 for $2.5 million.
Commonwealth Bank at the time owned a 35.9% stake in CountPlus, but said at the time it "intends, subject to market conditions, to sell its shareholding in an orderly manner over time following completion of the transaction''.
The bank has indeed been doing that, with its most recent announcement to the ASX showing its stake had fallen from 18.9% to 17.6%.
So why hasn't the bank sold all of its stake yet?
Broker Canaccord Genuity, in a research note published on 19 November, said the bank had agreed to indemnify Count against the court case, but that didn't necessarily stop it selling its shares.
But, CG said, "we are of the view it slowed CBA's intention to exit the CUP register as CBA management did not want to appear to have exited their position whilst there was uncertainty with respect to the court case – even though CBA had provided financial certainty with their indemnity''.
The broker added:
We expect the conclusion of the appeal allows CBA a clearer path to exit their position per their stated aim and consistent with their behaviour where the non participation in recent capital raising has progressively reduced their holding.
While a major shareholder selling out could be considered a bad thing, CG suggests it could allow other institutions to join the share register, and hence be a positive.
And either way, they argue the company's financials "remain robust''.
Kicking goals on the business front
The company's most recently-reported figures do indeed look good.
Speaking on 9 November, the Chief Executive Officer, Hugh Humphrey, said that for the first quarter of FY27, revenue was up 23.2% on the same period last year, and underlying EBITA was up 66.6%.
CG certainly likes what it sees, with a price target of $2.30 on Count shares, compared with the current $1.62.
Foolish takeaway
The removal of the threat of the court case should be a tailwind for this company, which is growing revenue strongly.
Profits have grown solidly every year for the past three years according to ASX data, as has revenue, and if the company continues to execute, it should appreciate well.